ZELTIQ Aesthetics, Inc.
(NASDAQ : ZLTQ)

( )
ZLTQ After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.98%628.331.0%$845.71m
DHRDanaher Corp. 2.13%313.450.7%$787.97m
MDTMedtronic Plc 1.82%112.250.6%$721.69m
ABTAbbott Laboratories -0.03%132.430.8%$684.68m
ISRGIntuitive Surgical, Inc. 5.16%340.490.8%$527.81m
DXCMDexCom, Inc. 6.48%558.407.8%$419.12m
BDXBecton, Dickinson & Co. 1.73%250.391.0%$383.76m
SYKStryker Corp. 2.41%260.541.3%$373.40m
BSXBoston Scientific Corp. 1.72%41.401.0%$362.00m
ALGNAlign Technology, Inc. 4.35%666.726.4%$339.55m
EWEdwards Lifesciences Corp. 3.22%115.560.4%$288.80m
AAgilent Technologies, Inc. 1.63%153.941.6%$259.09m
ZBHZimmer Biomet Holdings, Inc. 2.33%128.411.7%$232.19m
IDXXIDEXX Laboratories, Inc. 3.25%611.433.8%$226.28m
PKIPerkinElmer, Inc. (United States) 2.16%185.402.4%$173.66m

Company Profile

Zeltiq (pronounced Zel ′teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue. The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.